Literature DB >> 4661092

Serum-mediated blocking of cell-mediated anti-tumor immunity in a melanoma patient: association with BCG immunotherapy and clinical deterioration.

N L Levy, M S Mahaley, E D Day.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4661092     DOI: 10.1002/ijc.2910100203

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  7 in total

Review 1.  Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties.

Authors:  E Lederer; A Adam; R Ciorbaru; J F Petit; J Wietzerbin
Journal:  Mol Cell Biochem       Date:  1975-05-30       Impact factor: 3.396

2.  Lymphocyte responsiveness to phytohemagglutinin (PHA) and serum inhibitory effect in patients with gastric cancer.

Authors:  T Toge; H Ikeda; N Senoo; M Niimoto; T Hattori
Journal:  Jpn J Surg       Date:  1976-12

Review 3.  [The immunology of malignant melanoma (author's transl)].

Authors:  G Schieferstein
Journal:  Klin Wochenschr       Date:  1978-03-15

4.  Evaluation of host immunity in human neoplasia. 1. Discussion.

Authors: 
Journal:  Br J Cancer Suppl       Date:  1973-08

5.  Immunotherapy as an adjunct to surgery in the treatment of cancer.

Authors:  F R Eilber; E C Holmes; D L Morton
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

6.  Effect of chemotherapy and immunotherapy on tumor-specific immunity in melanoma.

Authors:  M S Mitchell; M B Mokyr; J M Davis
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

Review 7.  Modulation of the immune response by BCG: a review.

Authors:  R I Murahata; M S Mitchell
Journal:  Yale J Biol Med       Date:  1976-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.